These Funds Have Scary Fees
We don’t rate the priciest funds. It’s not likely worth the effort to tell you why you shouldn’t buy Nysa (NYSAX) and its 4.57% expense ratio or Midas Magic (MISEX) for 3.49%. (Side note: The SEC name rule requires Midas Magic to be at least 80% magic.) But there are some notable funds with fairly high fees. It’s a shame because these funds do have some appeal outside of their fees. A choosy investor can do better.
Eventide Gilead (ETGLX)
Until recently, this fund had been a really strong performer. But we gave it a Morningstar Analyst Rating of Neutral even before its recent tailspin in part because it charges an expense ratio of 1.35% and its high turnover rate likely means it racks up above-average trading costs. Manager Finny Kuruvilla also faces the challenge of managing a much larger fund than he had been running. The fund has had inflows of $1.1 billion over the past 12 months through September, which drove assets up to $1.8 billion. The strategy combines Christian screens and an aggressive-growth strategy. It will be interesting to see whether the fund’s success is sustainable, but its fees will make that a real challenge.
Russel Kinnel does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.